Resources

Africa on the Move

Leprosy lives on in Nigeria, 20 years after its ‘elimination’ as a public health problem

A coalition of leprosy organizations known as the Global Partnership for Zero Leprosy launched with a mission to end the disease once and for all.

Conference emphasizes need for partnership to create a world without leprosy

Sasakawa also acknowledged that in other areas — such as the partnerships and networking — there has been great progress. The Global Partnership for Zero Leprosy network was a significant step forward.

How COVID-19 adds to the challenges of leprosy-affected people

According to a report published by Global Partnership for Zero Leprosy, 76 percent of leprosy-affected people in 26 countries have been adversely affected by the pandemic.

Fear and loathing of leprosy

Bill Gallo of the Global Partnership with Zero Leprosy discusses leprosy prevalence. In Ethiopia, people with leprosy face stigma and challenges.

Unity is Strength: Conviction and Commitment with Foundation Raoul Follereau

Dr Roch Christian Johnson, President of the International Leprosy Association and medical advisor to Foundation Raoul Follereau (FRF), speaks about the collaboration between FRF and the Global Partnership for Zero Leprosy.

Uganda targets to end leprosy by 2030

Dr Stavia Turyahabwe spoke with the Uganda Broadcasting Corporation (UBC) about the country’s commitment to ending leprosy.

Ghana Health Service says Universal Health Coverage must cover leprosy

Dr Patrick Kuma-Aboagye, Director General, Ghana Health Service (GHS), has called for the inclusion of leprosy in the Universal Health Coverage agenda.

About GPZL

The Global Partnership for Zero Leprosy is a coalition of people committed to ending leprosy, also known as Hansen’s disease.

FAQ about SDR-PEP

Providing PEP to people who may have been exposed to leprosy will reduce their risk of developing leprosy by 60%.

Fact sheet: COVID-19 Crisis and Persons Affected by Leprosy

Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.

Policy for Images, Photos, and Language

All written materials, spoken words, photographs, or imagery used by the ILEP Federation must be used with integrity to respect and promote the dignity and honour of all persons affected by leprosy.

Zero Leprosy Country Model

We bring together partners in-country and international stakeholders to work on country-led customized strategies that address local needs and priorities to end leprosy.

2020 Impact Report

The Partnership shifted attention to COVID-19 response in 2020 and made progress in the country partnerships, research, and resource mobilization needed to reach zero leprosy.

Leprosy in Asia

The Southeast Asian and Western Pacific Regions account for 75% of new leprosy cases globally.

Zero Leprosy PEP Toolkit

SDR-PEP Resources and Tools

Single Dose Rifampicin Post-Exposure Prophylaxis (SDR-PEP) is a preventative treatment for leprosy that can be used to stop the transmission of leprosy to close contacts of leprosy patients. The treatment consists of a single dose of the antibiotic rifampicin (SDR).

This page features resources and tools from GPZL and partners with information for National Leprosy Programme Managers and implementing partners to inform their approach to SDR-PEP.

Help Desk

If you have a question about a best practice or tool, members of our Operational Excellence working group and those who have helped to develop the tools, can help.

Glossary

Members, abbreviations, and key terms we use to discuss leprosy.

17 February 2022 · Global Partnership for Zero Leprosy

World Leprosy Day 2022: Events Around the World

World Leprosy Day is recognized internationally on the last Sunday of January to increase public awareness of leprosy, also known as Hansen’s disease. This year it was celebrated on 30 January 2022. Organizations of persons affected by leprosy and leprosy community partners traditionally organize in-person … Read More >

Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study

The Lancet published the following report, “Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study.”